About this trial
Pseudoexfoliation syndrome is associated with alterations in the biomechanical properties of the cornea. This prospective observational cohort study aims to evaluate changes in corneal biomechanical properties after standard phacoemulsification cataract surgery in patients with pseudoexfoliation syndrome compared with patients without pseudoexfoliation syndrome. Corneal hysteresis (CH) and corneal resistance factor (CRF) will be measured using the Ocular Response Analyzer before surgery and at postoperative day 1, day 7, and day 30. The study will enroll patients undergoing routine cataract surgery to compare postoperative changes in CH and CRF between the pseudoexfoliation and control groups.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
adults aged 50 years and older
presence of age-related cataract requiring phacoemulsification cataract surgery
presence of pseudoexfoliation syndrome (PEX group) or absence of pseudoexfoliation syndrome (control group)
ability and willingness to provide written consent
Disqualifiers
previous ocular surgery,
corneal disease,
glaucoma or ocular hypertension,
dry eye disease (Schirmer test <10 mm, tear break-up time <5 seconds or positive fluorescein staining),
Trial population
Adults with age-related cataract scheduled for routine phacoemulsification cataract surgery. Participants will be enrolled into either the pseudoexfoliation syndrome group or the control group and followed for 30 days after surgery
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Change in corneal hysteresis (CH)
Change in corneal hysteresis measured by Ocular response analyzer before cataract surgery and at postoperative day 1, day 7 and day 30. Changes will be compared between patients with pseudoexfoliation syndrome and controls.
Secondary outcomes
Change in corneal resistance factor (CRF)
Change in corneal resistance factor measured by Ocular response analyzer before cataract surgery and at postoperative day 1, day 7 and day 30. Changes will be compared between patients with pseudoexfoliation syndrome and controls.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Kata Culina
Lead sponsor
Eye Clinic Medic Zuljan Jukic
Sponsor institution
This trial is not recruiting at the moment. You can still explore other options: